Opening Asia for Russia

At the meeting of APEC leaders called for an end to vaccine nationalism

22.07.2021 106 просмотров

It is necessary to put an end to vaccine nationalism - such a statement was made by Philippine President Rodrigo Duterte at an informal meeting of economic leaders of the Asia-Pacific Economic Cooperation Forum. 

The politician noted that more than 80 percent of COVID-19 vaccine shipments have been shipped to rich countries, while developing countries are experiencing serious shortages of these drugs.

“The big imbalance in access to vaccines needs to be corrected. Vaccine nationalism must be ended, President of the Philippines said. "How can countries have a stockpile of weapons capable of destroying us all, but not a stockpile of vital vaccines and medical equipment that can save us all?"

ASEAN Vaccine 03.jpg

Duterte urged countries to ensure fair and safe access to vaccines, emphasizing that effective mass vaccination is the key to world economic recovery. Russian President Vladimir Putin supported his Philippine counterpart, noting that the problem of availability and fair distribution of tests, vaccines, medicines and protective equipment against COVID-19 has indeed not been resolved.

ASEAN Vaccine 04.jpg

high risks, we see the expansion of the scale of vaccination as a top priority, the Russian leader stressed. -  We are ready for close cooperation with APEC partners in such topical areas as the organization of mass immunization of the population, including labor migrants, rehabilitation and restoration of the health of those who have been ill.

 ASEAN Vaccine 02.jpg

Vladimir Putin said that Russia is actively promoting the localization of the production of domestic drugs abroad on the basis of technology transfer. Contracts for the production of the Sputnik V vaccine have been signed with a number of foreign enterprises, including those from the APEC economies. The total production volume is more than 800 million doses per year. The President noted that it is important to continue to work together to create new capacities for the production of vaccines in the Asia-Pacific region, to eliminate administrative and other barriers that hinder their production and supply.

Новости партнёров